Refine by
Pharmaceutical And Life Science Articles & Analysis: Older
147 news found
Profacgen, a leading provider of custom biotechnology services, is pleased to announce significant updates to its Antimicrobial Peptides (AMPs) Services, enhancing its capabilities to support the growing demand for alternative therapies in the fight against drug-resistant pathogens. As antibiotic resistance continues to pose a global health threat, Profacgen is expanding its services to assist ...
Ace Therapeutics is proud to announce the launch of its cardiovascular disease model development services, aiming to empower researchers and pharmaceutical companies with advanced tools and models to accelerate the study of cardiovascular diseases and drug discovery. Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality worldwide, underscoring the urgent need for ...
This new initiative is set to advance research in glaucoma treatments, offering comprehensive support and innovation for researchers and pharmaceutical companies aiming to cure this pervasive eye disease. Glaucoma is a group of eye conditions that damage the optic nerve, often due to abnormally high intraocular pressure. ...
In the ever-evolving landscape of pharmaceutical research and development, the demand for innovative and efficient drug discovery methods is more pressing than ever. At the forefront of this demanding field is Protheragen-ING AI-Pharma, a contract research and development biotechnology company, offering cutting-edge solutions to researchers through its AI-powered drug discovery and design ...
Veolia Water Technologies has launched its mobile water services offering to the pharmaceutical, cosmetics and life science industries across Europe. This initiative provides a comprehensive range of technologies and services bundled as a rental service to deliver reliable, uninterrupted and sustainable solutions for manufacturing, cleaning, and ...
From established up to now, Ace Therapeutics has collaborated with leading pharmaceutical companies and research institutions to advance their research goals and bring cutting-edge therapies to patients in need. Together, Ace Therapeutics and its partners are committed to revolutionizing the field of life science research for the benefit of ...
This novel glucagon-like peptide-1 (GLP-1) receptor agonist has generated significant excitement within the pharmaceutical and life sciences industries due to its remarkable efficacy in managing type 2 diabetes. ...
Ace Therapeutics is a preclinical contract research provider engaged in metabolic disorders, infectious diseases and parasites, neurological disorders, ophthalmic diseases, gastrointestinal disorders, and immune system diseases. With the rise of antibiotic-resistant bacteria posing a significant threat to global public health, Ace Therapeutics announces its new vaccine development services to ...
Huateng Pharma, a global leader in PEG derivatives and a premier CDMO for APIs and intermediates, is excited to announce the launch of its latest product, Y-Shape PEG NHS. This cutting-edge Succinimidyl Carboxymethyl Ester branched 2ARM PEG offers a revolutionary approach to amine PEGylation, enhancing the modification of proteins and other biologics. PEGylation, the technique of attaching a PEG ...
With years of experience in the pharmaceutical and life science sectors, CD Bioparticles announces its advanced line of multiplex fluorescence particles designed to streamline complex biological assays in flow cytometry experiments. ...
CD ComputaBio, a pioneering provider of computational biology services, has recently introduced its advanced Computer-Aided Drug Design (CADD) services, revolutionizing the drug discovery landscape. Through the utilization of cutting-edge computational chemistry techniques, CD ComputaBio aims to streamline and enhance the process of drug discovery for pharmaceutical companies, research ...
Shanghai, China – June 14, 2024 – Hunan Huateng Pharmaceutical Co., Ltd., a global leader in the production of PEG derivatives and Contract Development and Manufacturing Organization (CDMO) services for Active Pharmaceutical Ingredients (APIs) and intermediates, is excited to announce its participation in CPHI China 2024. The event will take place from June 19 to 21, 2024, at the Shanghai New ...
[Cambridge, June 8, 2024] Protheragen-ING is pleased to announce its participation in the 26th SAPA-NE Annual Conference. The event will be held at the Cambridge Marriott Boston (50 Broadway, Cambridge, MA 02142), on June 8, 2024, 9 am - 5 pm EDT. About SAPA-NE SAPA (Sino-American Pharmaceutical Professionals Association) is one of the most active and largest Chinese-based biopharmaceutical ...
CD Formulation, an expert in the pharmaceutical research and development field, has announced the expansion of its comprehensive pharmacological services to support the burgeoning sector of veterinary drugs. The move is poised to elevate the standard and efficacy of veterinary pharmaceuticals, reinforcing CD Formulation’s dedication to the well-being of animals globally. “Our ...
In a major development poised to benefit the scientific community, Alfa Chemistry has recently unveiled an expanded catalog featuring an extensive range of phosphine ligands, nitrogen-donor ligands, and oxygen-donor ligands. This addition underscores the company's commitment to providing high-quality chemical reagents and catalysts to enhance research and industrial processes across various ...
Alfa Chemistry, a renowned chemical supplier, has recently unveiled a wide range of halide quaternary ammonium salts, encompassing fluoride, chloride, bromide, and iodide series. These newly released products are aimed to meet the increasing demands of various industries for high-quality chemicals. With a history of providing top-notch chemical products, Alfa Chemistry has established itself as a ...
CD Formulation is making waves in the pharmaceutical industry with its innovative drug delivery technologies. With a focus on sustained and controlled release formulations, as well as liquid, semi-solid, injectable, and nanoformulations, CD Formulation is at the forefront of the industry's efforts to enhance drug efficacy. One of CD Formulation's key technology platforms is its sustained ...
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has recently expanded its low PDI polymer portfolio and announces its new offering of Polyolefin Family polymers with a wide range of properties that make them well-suited for a variety of drug delivery applications. Low dispersion index polymers are polymeric compounds with low molecular weight ...
Alfa Chemistry, a leading chemical supplier and service provider, has recently announced the expansion of their selection of click chemistry reagents. This development aims to better serve the needs of researchers and scientists working in the field of click chemistry, a powerful method for assembling complex molecular structures quickly and efficiently. Click chemistry has gained significant ...
In the quest to develop safe and effective medicines, pharmaceutical companies rely on the precise combination of active pharmaceutical ingredients (APIs) and excipients. These crucial components play a pivotal role in the formulation of pharmaceutical drugs, ensuring optimal drug delivery and patient outcomes. Recently, CD Formulation released a comprehensive guide titled "Active Pharmaceutical ...